Neko Health Raises $700 Million in Series C Funding

Neko Health raised $700 million in a Series C funding round led by Lightspeed Venture Partners and O.G. Venture Partners. The round follows the company's $260 million Series B completed in January 2025. The startup operates clinics that deliver 60-minute scans assessing skin health, blood sugar, blood abnormalities, and risks for metabolic syndrome, stroke, and heart attack.

The scan now incorporates body composition data and can integrate with Apple Health records.

The company stated that more than 100,000 people have completed scans and more than 350,000 have registered for the waitlist or booked appointments. It is preparing to open its first U.S. location in New York. Other participants in the Series C included Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD.

Calm founder Alex Tew said a Neko Health scan detected a malignant mole that was later removed. The company has reported more than 100,000 scans completed to date.